ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39 | -15.2% | 50,061 | 0.0% | 0.00% | – |
| Q2 2023 | $46 | -100.0% | 50,061 | -85.3% | 0.00% | – |
| Q3 2022 | $366,000 | -14.9% | 340,068 | +34.6% | 0.00% | – |
| Q2 2022 | $430,000 | – | 252,682 | +2297009.1% | 0.00% | – |
| Q3 2021 | $0 | – | 11 | -77.6% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 49 | -99.4% | 0.00% | – |
| Q1 2021 | $43,000 | 0.0% | 8,189 | +2.5% | 0.00% | – |
| Q4 2020 | $43,000 | -27.1% | 7,988 | +7.9% | 0.00% | – |
| Q3 2020 | $59,000 | -20.3% | 7,400 | 0.0% | 0.00% | – |
| Q2 2020 | $74,000 | +270.0% | 7,400 | 0.0% | 0.00% | – |
| Q1 2020 | $20,000 | +1900.0% | 7,400 | +1306.8% | 0.00% | – |
| Q4 2019 | $1,000 | -50.0% | 526 | -68.0% | 0.00% | – |
| Q3 2019 | $2,000 | -50.0% | 1,643 | +88.6% | 0.00% | – |
| Q1 2019 | $4,000 | +100.0% | 871 | +221.4% | 0.00% | – |
| Q4 2018 | $2,000 | +100.0% | 271 | +367.2% | 0.00% | – |
| Q3 2018 | $1,000 | -99.8% | 58 | -99.8% | 0.00% | – |
| Q2 2018 | $417,000 | +3.5% | 35,111 | -2.3% | 0.00% | – |
| Q1 2018 | $403,000 | +72.2% | 35,951 | +2.4% | 0.00% | – |
| Q4 2017 | $234,000 | -24.0% | 35,100 | -6.6% | 0.00% | – |
| Q3 2017 | $308,000 | – | 37,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $5,165,000 | 4.93% |
| Long Focus Capital Management, LLC | 4,429,491 | $9,125,000 | 1.17% |
| Endurant Capital Management LP | 2,160,890 | $4,451,000 | 1.17% |
| NEA Management Company, LLC | 17,082,611 | $35,190,000 | 1.02% |
| Matrix Capital Management Company, LP | 38,974,185 | $80,287,000 | 0.96% |
| Key Client Fiduciary Advisors, LLC | 420,447 | $866,000 | 0.68% |
| ACT CAPITAL MANAGEMENT, LLC | 90,000 | $185,000 | 0.20% |
| DAFNA Capital Management LLC | 351,064 | $723,000 | 0.19% |
| PFM Health Sciences, LP | 2,374,674 | $4,892,000 | 0.18% |
| Rock Springs Capital Management LP | 2,297,194 | $4,732,000 | 0.12% |